Binding sites for transcription factor nuclear factor one (NFI) proteins, encoded by four genes in the mouse, have been characterized from many tissue-specific genes. NFI genes are expressed in unique but overlapping patterns in embryonic and in adult tissues. Nfib is highly expressed in the embryonic lung. Here we show that Nfib null mutants die early postnatally and display severe lung hypoplasia. Heterozygotes do survive, but exhibit delayed pulmonary differentiation. Expression of transforming growth factor b 1 (TGF-b1) and sonic hedgehog (Shh) is not down-regulated in mutant lung epithelium at late stages of morphogenesis, which may result in incomplete lung maturation. Our study demonstrates that Nfib is essential for normal lung development, and suggests that it could be involved in the pathogenesis of respiratory distress syndromes in humans. q
Introduction
The embryonic lung arises from the laryngo-tracheal groove of the mouse foregut at embryonic day (E9.0-E9.5) with an outgrowth of paired lung buds that invades the mesenchyme. Histologically, four stages of lung development can be discerned (Ten Have-Opbroek, 1991) . At the pseudoglandular (E9.5-E16.6) stage, the bronchial and respiratory tree develops to form an undifferentiated primordial system. During the canalicular stage (E16.6-E17.4) the terminal lung buds dilate and the vascularization develops. At the terminal sac or saccular stage (E17.4 to postnatal day 5 (P5)), the mesenchyme thins down, vascularization continues, and type I and II pneumocytes differentiate. During the alveolar phase (P5-P30), the terminal sacs develop into mature alveolar ducts and alveoli.
A variety of knock out and transgenic models have been described that result in defects in respiratory organogenesis at all different stages of development: Foxa2 deficient mice show a defect of anterior foregut differentiation (Ang and Rossant, 1994) . The expression of a dominant negative FGF receptor 2 (Fgfr-2) in the distal respiratory epithelium directed by the surfactant protein C (SP-C) gene promoter completely blocks airway branching and epithelial differentiation, without prohibiting outgrowth (Peters et al., 1994) . EGF receptor (Egfr) null mutants have impaired branching and deficient alveolization and septation (Miettinen et al., 1997) . Fibroblast growth factor 9 (Fgf9) null mutant lungs exhibit reduced mesenchyme and decreased branching of airways (Colvin et al., 2001) . PDGF-A deficiency leads to failure of alveolar smooth muscle cell formation (Lindahl et al., 1997) . Fgfr3/Fgfr4 double deficient mice are completely blocked in alveogenesis (Weinstein et al., 1998) . Transcription factor Sp3 2/2 mice die shortly after birth, apparently of respiratory failure, with only slight morphological alterations of their lungs (Bouwman et al., 2000) .
Nuclear factor one (NFI) proteins comprise a family of sequence-specific DNA-binding proteins that bind to the canonical palindromic binding site 5 0 -YTGGCANNNTGC-CAR-3 0 , all with apparent identical affinity. They interact with double-stranded DNA as homo-and heterodimers via an amino terminal DNA-binding and dimerization domain (Kruse and Sippel, 1994) . NFI was originally identified as a host factor required for the replication of adenovirus DNA (Nagata et al., 1982 (Nagata et al., , 1983 and independently in chicken as a protein binding to the flanking region of the chicken lysozyme gene (Nowock and Sippel, 1982; Borgmeyer et al., 1984) . Later work indicated that these proteins are transcription factors that act on several cellular and viral promoters and enhancers (Nowock et al., 1985; Leegwater et al., 1986) . Binding sites for NFI proteins have since been identified in several tissue-specific and in developmentally regulated genes expressed in almost every tissue and organ (Gronostajski, 2000) , including the lung (Bachurski et al., 1997) . Cloning of NFI cDNAs from various vertebrate species revealed that NFI proteins are encoded by four closely related genes (Rupp et al., 1990; Kruse et al., 1991) . The four murine genes (Nfia, Nfib, Nfic, and Nfix) are expressed in unique but overlapping patterns in embryonic and in adult tissues (Chaudhry et al., 1997) . In adult mice, all four genes are most highly expressed in lung, liver, heart, and brain. The broad expression patterns lead to the hypothesis that the differential expression of NFI genes might result in differential expression of developmentally regulated genes. The first direct evidence for the important role of NFI proteins in development came from studies on Nfia deficient mice (das Neves et al., 1999) . Inactivation of the Nfia gene resulted in perinatal lethality, hydrocephalus, and agenesis of the corpus callosum.
To study the specific function of the Nfib gene during mouse development, we disrupted the DNA-binding domain of Nfib by gene targeting in embryonic stem cells, and introduced this null allele into the mouse germ line. Here we show that Nfib null mice are born alive, but die early after birth of respiratory failure associated with pulmonary atelectasis. Lungs from both heterozygous and homozygous mice are immature, but to a different extent, so only heterozygous mice do survive. We present evidence that NFIB function is crucial for the embryonic development of the lung.
Results

Generation of Nfib deficient mice
Successful disruption of the Nfib locus was obtained by introducing a lacZ reporter gene in frame into exon 2 of the Nfib gene together with a neomycin-resistant gene (neo) expression cassette under the separate control of the HSVtk promoter to generate the Nfib E2-lacZ allele (Fig. 1A) . This insertion into the region coding for the DNA-binding domain likely results in a null allele for the Nfib gene. An Nfib-lacZ fusion mRNA is generated containing only the first 11 codons of the Nfib gene (data not shown). Five independently targeted clones were identified by Southern blot analysis from 300 screened ES cell clones, resulting in a frequency of 1:60. Mutant clones were expanded and the homologous recombination event confirmed. Heterozygous Nfib mutant mice derived from germline chimeras appeared phenotypically normal and were intercrossed to generate homozygous mutants.
2.2. Homozygous mutant mice die early postnatally due to respiratory failure Nfib null mice are not viable and die shortly after birth due to respiratory failure. Genotyping of fetuses obtained from Caesarean section (C-section) at E18.5 (Fig. 1B) shows no statistically significant loss of Nfib 2/2 mutant individuals up to birth. Close monitoring of E18.5 embryos as well as litters after birth revealed that Nfib 2/2 mice were born alive and made visible efforts to breathe. However, in contrast to their wild-type and heterozygous littermates, Nfib null mice become cyanotic and die within 15 min postpartum (Fig. 1C) . All homozygous mutant E18.5 embryos and neonates have open eyes, resulting from a failure of eyelid fusion (Fig. 1C) . Autopsies of dead E18.5 embryos or neonates reveal that they all have air in their stomach and intestine, suggesting that these mutant animals failed to breathe properly. Lungs dissected from null mutant embryos or neonates do not float on water, indicating that their lungs were never inflated with air. While lobation of the mutant lungs appear to be comparable to wild-type littermates, lung weight and size are altered in mutant mice (Table 1 ). The wet lung weight compared to body weight is lower in wildtype mice (3.1%) than in heterozygous (3.6%) and homozygous mutants (4.4%). However, there is no difference in the lung dry weight between wild-type and mutant littermates (data not shown).
Lung development is delayed in mutant mice
To understand the cause of the respiratory failure, skeletal preparations were examined. No malformation of ribs, larynx, trachea, or other skeletal elements that could explain the respiratory distress was found (data not shown), suggesting instead a functional problem in the lung. Histological examination at E16.5 does not detect major difference between mutant and wild-type lung tissues ( Fig. 2A-C) . Nevertheless, branching morphogenesis is slightly inhibited. However, at E18.5 and shortly after birth the lungs of heterozygous and homozygous mice appeared immature (Fig. 2E,F) . The lungs from heterozygous animals are slightly hypoplastic and premature, having their development delayed at the late canalicular stage (Fig. 2E ) with only focal transition of tissue to the terminal sac stage. The mesenchymal compartment is increased and the interalveolar septae are thicker, compared to wild-type (Fig. 2D) .
The lungs of homozygous mutant mice show severe hypoplasia and fail to develop beyond the late pseudoglandular or early canalicular stage (Fig. 2F ). Lobar branching from the primary bronchi has occurred and further branching generated an undifferentiated primordial respiratory system; terminal sacs are not detected in E18.5 lungs (Fig.  2F ). Types I and II pneumocytes are not differentiated (Fig. 4B, D) . A dense dichotomic respiratory tree is embedded within the extensive mesenchyme. Cross-sections show a gland-like organization (Fig. 2G ). All these results indicate that a functional lung is never formed in the Nfib null mice, providing an explanation for the respiratory distress. Besides the lung and eyelid phenotypes, no other malformation was detected in the mutant in extensive histopathological examinations, despite Nfib expression in many different tissues and organs.
The expression pattern of lung-specific genes is altered in mutant animals
The histopathological examination suggested that lung development is impaired in Nfib mutant mice. Nfib is expressed in the developing wild-type lungs (Fig. 3) . At embryonic stage E14.5, both the epithelium and the mesenchymal tissue express Nfib (Fig. 3A) . During further Table 1 Body and lung weight (g) of E18.5 embryos delivered by Caesarean section (three litters) lung differentiation, Nfib expression maintains in the mesenchyme, but attenuates in the epithelium (Fig. 3B,C) , so that at E18.5 only the mesenchyme expresses Nfib.
To understand the mechanisms for the mutant phenotype, we first investigated the extent to which lung-specific differentiation proceeded to occur in mutant lungs. Synthesis of surfactant is a typical characteristic of the late stages of lung development. Surfactant is essentially composed of phospholipids and four surfactant proteins (SPs): SP-A, SP-B, SP-C, and SP-D. In wild-type mice these proteins are expressed in the alveolar type II cells and the non-ciliated bronchiolar epithelial cells. In the lungs of E18.5 mutant embryos, expression of all these proteins was similarly reduced, as estimated by Northern blot analysis (not shown). However, their distribution within the tissue is not affected, remaining similar to that in wild-type lungs at an equivalent stage of development. Immunohistochemical analysis using specific antibodies against SP-A (Fig.  4A,B) , SP-B, SP-C, and SP-D (data not shown), showed the SPs localized to distal epithelial cells and type II pneumocytes. Mutant tissues without type II pneumocytes express the SPs only in the immature distal epithelia or terminal buds, as shown for SP-A (Fig. 4B ). An anti-Ecadherin antibody as an epithelial marker to detect all epithelial cells in the lung (Fig. 4C,D) showed the developmentally immature phenotype of the lung tissue of Nfib null mutants at E18.5.
2.5. Mutant lungs fail to repress transforming growth factor b 1 (TGF-b1) and sonic hedgehog (Shh) expression during development
We performed protein expression analysis of a number of factors involved in lung epithelial morphogenesis on E16.5 and E18.5 lungs, to elucidate the molecular mechanisms responsible for the Nfib mutant lung phenotype. TGF-b proteins have been implicated in the regulation of fetal lung development (Heine et al., 1990; Kaartinen et al., 1995) and TGF-b1 has an inhibitory effect on lung epithelial differentiation in fetal lungs in vivo (Zeng et al., 2001) . To test whether TGF-b signaling is affected in the mutants we performed immunohistochemical staining for the TGF-bs (TGF-b1, b2, b3) and their types I and II receptors. Only the expression of TGF-b1 was abnormal in the mutant lungs ( Fig. 5A-D) . At embryonic stage E16.5 the expression pattern of TGF-b1 in the distal epithelium is similar in wild-type (Fig. 5A ) and mutant lungs (Fig. 5B) . However, in contrast to the lungs of wild-type littermates (Fig. 5C ), expression of TGF-b1 is not repressed in the distal lung epithelium of Nfib mutants (Fig.  5D ) at E18.5. The immature distal lung epithelia still express high levels of TGF-b1. On the contrary, the expression of TGF-b2 and TGF-b3 was attenuated in mutant and wildtype lungs (data not shown). The expression of TGF-b type I receptor (TGFbRI) (Fig. 5E-H) and TGF-b type II receptor (data not shown) in the distal epithelia is not altered in mutant, compared to wild-type lungs.
Sonic hedgehog (Shh) has also been implicated in lung branching and epithelial morphogenesis (Bellusci et al., 1997; Pepicelli et al., 1998) . To test whether the expression patterns of Shh are affected in the mutant, we performed in situ hybridization on E16.5 and E18.5 lung sections (Fig.  5I-L) . At E16.5 wild-type (Fig. 5I) does not express Shh, and mutant distal epithelia expresses Shh very weakly (Fig.  5J) . However, at E18.5, whereas wild-type distal epithelia are negative for Shh (Fig. 5K) , the developmentally delayed distal lung epithelium of mutant lungs still expresses Shh ( Fig. 5L) . This indicates that the down-regulation of Shh, normally observed at the late stages of lung development, failed to occur in the absence of Nfib.
Discussion
Nfib null mutant mice die due to lung dysfunction
In this study we show that Nfib is essential for postnatal survival. At birth the ratios of homozygous, heterozygous, and wild-type animals for the Nfib E2-lacZ allele showed normal Mendelian distribution, indicating that the mutation does not result in embryonic lethality. However, Nfib-null mutant mice die within 15 min postpartum due to respiratory distress. Besides the lung phenotype, the only obvious phenotypic defect of these mutants was open eyes. A number of spontaneous mouse mutations, e.g. open eyelid (oe), lid gap (lg), and eyelids open at birth (eo) (Lyon and Searle, 1989) , as well as targeted mutations, e.g. in the inhibin b B gene (Inhbb) (Schrewe et al., 1994) and the cabl proto-oncogene (Schwartzberg et al., 1991) have been described as showing a similar mutant eye phenotype. However, other phenotypic effects of these mutated genes are not similar to Nfib deficiency, suggesting that the openeye phenotype may result from alterations in several different developmental pathways.
Other organs known to express the Nfib gene appeared normal, suggesting that in them Nfib is redundant and that its loss is possibly compensated by the expression of other NFI genes. In addition, the Nfib mutant phenotypes have no overlap with the phenotype of the Nfia null mouse (das Neves et al., 1999; A.G., A.E.S. and H.S., unpublished).
Nfib mutants exhibit retarded pulmonary development
While lung size and lobation appears normal, comparison of the lung weight shows that the wet weight, but not the dry weight is different between genotypes. Nfib 2/2 lungs have a 40%, Nfib 1/2 lungs a 16% higher wet weight than wild-type lungs. During birth and very shortly after birth mammals normally expel remaining amniotic fluid out of their lungs; it is likely that this process is inhibited in the mutants, resulting in higher wet weights of excised lungs in mutants.
The histological structure of mutant lungs was clearly affected. Nfib 2/2 mutant lungs of E18.5 embryos or neonates revealed that lung development was arrested at the late pseudoglandular stage. Although branching morphogenesis was slightly inhibited, lung mass is almost unaffected. Angiogenesis within the mesenchyme starts very sporadically within the lungs. All these observations match the criteria of an embryonic lung tissue at the late pseudoglandular stage (Ten Have-Opbroek, 1991 Continued postnatal maturation of the lungs proceeds and the lung histology is indistinguishable from that of wildtype mice at 8 weeks postpartum. Our data suggest that the gene dosage of Nfib is critical for lung development. It is generally assumed that most mammalian genes are transcribed from both alleles and the vast majority of human disease syndromes and targeted mutations in the mouse are recessive. However, a minority of genes is semi-dominant, thus heterozygous loss-of-function mutations in these genes leads to phenotypic abnormalities, as seen in the lungs of Nfib 1/2 mice. Such haploinsufficiency has been described among other genes, for five of the nine mammalian Pax genes, which are associated with mouse developmental mutants and human disease syndromes (Nutt and Busslinger, 1999) , the Sox9 gene (Bi et al., 1999 (Bi et al., , 2001 ) and the Foxf1 gene (Mahlapuu et al., 2001 ).
Mutant lungs fail to down-regulate Tgfb1 and Shh expression
Our observation that TGF-b1 (but not TGF-b2 or TGF-b3)
A. Gründer et al. / Mechanisms of Development 112 (2002) 69-77 74 Fig. 5. Expression analyses of TGF-b1, TGF-b receptor type I (TGFbRI) and sonic hedgehog (Shh) on wild-type and Nfib mutant embryonic lungs at E16.5 and E18.5. Mutant and wild-type lungs show a similar expression of TGF-b1 in the distal epithelium (de) at E16.5 (A, B) whereas at E18.5 TGF-b1 expression is detectable only in mutant (arrow) (D), but not in wild-type lungs (C). TGFbRI expression is detectable at comparable levels in E16.5 wild-type and mutant lungs (E, F). In wild-type lungs at E18.5 TGFbRI is expressed in the bronchi (b) (G). The mutant lungs show TGFbRI expression in the bronchi and throughout the premature distal epithelium (H). Sonic hedgehog (Shh) expression absent from wild-type (I), but very weak in mutant lung epithelium at E16.5 (J). At E18.5, mutant but not wild-type lungs show expression of Shh in the distal epithelium (arrowhead) (K, L). as, air sacs; b, bronchi and bronchioles; de, distal epithelium. Bars: (A-H) 10 mm, (I-L) 5 mm.
and Shh expression remain high during lung development of Nfib mutant mice led us to suggest that continued expression of TGF-b1 and/or Shh in the distal respiratory epithelium is responsible for the lung hypoplasia. TGF-bs (Pelton et al., 1990 (Pelton et al., , 1991 and Shh (Bellusci et al., 1997) are expressed during fetal lung development and both signaling pathways have been implicated in the normal spatio-temporal pattern of lung morphogenesis (Serra et al., 1994; Bellusci et al., 1997) . Furthermore, addition of exogenous TGF-b1 and -b2 to E11.5 embryonic mouse lungs in culture results in branching inhibition and in hypoplastic phenotypes (Serra et al., 1994) , indicating that TGF-b ligands exert negative regulatory influences on lung morphogenesis. On the other hand, abrogation of TGF-b type II receptor signaling stimulates lung morphogenesis (Zhao et al., 1996) . A similar arrest of lung development as seen in the Nfib 2/2 mice has been reported in E18.5 lungs of SP-C-TGF-b1 (Zhou et al., 1996) and SP-C-Shh (Bellusci et al., 1997) transgenic embryos. In these transgenics, TGF-b1 and Shh, have been overexpressed in the distal respiratory epithelium directed by the human SP-C gene promoter. In each case, transgene expression blocked sacculation of the distal respiratory tract and inhibited branching and epithelial cell differentiation in the lungs. The Nfib null mutants resemble animals with TGF-b1 and Shh overexpression in their lungs, not only in expression, but also in phenotype. It would be interesting to know if a mild hypoplasia, as seen in our Nfib heterozygotes, could be achieved in transgenics with moderate transgene expression. Many transgenic models display variation in the severity of the phenotype depending on the copy number of the transgene (Kanzler et al., 1998 (Kanzler et al., , 2000 . It is likely that Nfib directly or indirectly down-regulates the expression of Tgfb1 and/or Shh. In Nfib mutants no (Nfib ) are made, leading to continued expression of the Tgfb1 and Shh in the lung epithelium. The excess of signaling thereby results in inhibition of some branching but mainly of epithelial morphogenesis, leading to retarded lung development. So far, analysis of the effect of NFI proteins on the expression of TGF-bs or Shh has not been described, but by using the transcription factor binding site prediction program TESS (University of Pennsylvania, USA) we localized a NFI DNA-binding site within the upstream region of the Tgfb1 gene (Guron et al., 1995) . In contrast to the Tgfb1 gene, there are no potential sites in the Shh gene promoter (Epstein et al., 1999) , suggesting an indirect mechanism of regulation. From our studies we cannot determine if Tgfb1 and Shh are direct or indirect targets of Nfib or one gene is under the control of the other. In one study on the development of skin appendages in chicken it was suggested that TGF-b2, but not TGF-b1, expressed by the epithelial placode, is downstream of Shh (Ting-Berreth and Chuong, 1996) . In lung development the regulatory hierarchy remains to be determined.
Tgfb3 2/2 mice show a similar hypoplastic phenotype (Kaartinen et al., 1995) , but we do not postulate a direct effect of Nfib on the Tgfb3 gene because its expression is not altered in Nfib mutants. Nonetheless, it would be interesting to know if Tgfb1 or Shh expression remains high in the pulmonary epithelium of these mutants, as this might lead to the delay in lung morphogenesis.
Relevance of Nfib mutants for human disorders
Nfib deficiency clearly demonstrates the importance of this factor in pulmonary maturation. Nfib mouse mutant neonates display abnormal pulmonary histology, closely resembling that of premature human infants. Pulmonary hypoplasia, especially mild hypoplasia, is an important and still underestimated cause for fetal atelectasis, the perinatal death of human newborns. The diagnosis can only be confirmed by elaborate counting of alveolar spaces and not by simple lung weight determination (Thurlbeck, 1992) . The grade of hypoplasia decides whether the newborns survive or how severe the consequently developing respiratory distress syndrome (RDS) will be. Several factors like anencephaly, diaphragmatic hernia, hydrops fetalis, kidney anomalies, tracheal anomalies, or maternal hypoxia are known to develop hypoplasia. These anomalies have not been found in the mouse Nfib mutants, arguing against an involvement of Nfib in these disorders. However, TGF-b1 activity is markedly increased in bronchoalveolar lavage fluid obtained from premature human infants at risk for developing bronchopulmonary dysplasia (Kotecha et al., 1996) . Furthermore, alveolar hypoplasia in rat is associated with high levels of TGF-b activity in premature lungs (Blanco and Frank, 1993) . Therefore, it would be important to analyze possible mutations in the NFIB gene in human patients. Although Nfib heterozygous mice do not show any viability defects under regular mouse facility conditions, it is possible that these animals are more susceptible to lung dysfunction under stress conditions or to pulmonary infections. It would be interesting to know if the embryonic haploinsufficiency has consequences in adult mutant animals. We conclude from our studies that expression of Nfib is critical for normal lung development in mice and our study clearly indicates that the loss of diploid NFIB expression should be considered as a possible cause of pulmonary disorders causing respiratory distress in human infants or lung dysfunctions in adults.
Experimental procedures
Construction of a nuclear factor I B (Nfib) gene targeting vector
The genomic DNA for the Nfib gene was isolated from a 129/Sv lPS genomic library (Nehls et al., 1994) using the Nfib cDNA as a probe. The localization of exon 2 was confirmed by Southern blot analysis and by DNA sequencing with exon 2 specific primers. A 6.5 kb fragment, containing the second exon, was used for the construction of the targeting vector. A lacZ-neo r -cassette was cloned into the EcoRI site of exon 2, thereby, fusing the lacZ gene in frame with the Nfib gene and eliminating the EcoRI site. The insertion into exon 2 resulted in 1.8 kb 5 0 and 4.7 kb 3 0 region of homology. The targeting construct was then inserted into the BamHI site of the lKO vector (Nehls et al., 1994) , thereby, flanking the targeting construct with a HSV-tk cassette at both ends. The resulting plasmid was linearized with NotI.
Homologous recombination in ES cells and generation of gene-deficient mice
CJ7 ES cells were electroporated and selected as described (Swiatek and Gridley, 1993) . DNA was isolated from colonies in replica plates by the method of Ramírez-Solis et al. (1993) . Clones positive for homologous recombination were identified by Southern blot analysis of EcoRIdigested genomic DNA. Mutant ES cells were injected into C57Bl/6 blastocysts as described (Schrewe et al., 1994) . Male chimeras exhibiting extensive coat-color chimerism were bred to C57Bl/6 females to test for germ line transmission. F1 animals heterozygous for the Nfib E2-lacZ mutation were intercrossed to generate homozygous offspring. Embryos at embryonic stage E16.5 were dissected out in phosphate buffered saline (PBS). Embryos at E18.5 were delivered by C-section as described (Mann, 1993) and then monitored while lying on a 378C warming platform. Genotypes were determined by Southern blotting analysis using EcoRI digested DNA and an external probe. For polymerase chain reaction (PCR) analysis, the wild-type Nfib allele was detected by using a 5 0 primer (P1: 5 0 -TGTCCAATTCTTCTTCCCCA-3 0 ) and a 3 0 primer (P2: 5 0 -GCTCCTGCACGTAGTATGCC-3 0 ). This primer pair flanks the lacZ-neo insertion and amplifies a 560 bp fragment from the wild-type allele. To detect the mutant allele primer P1 and a primer within the lacZ gene (P3) were used to amplify a 3 kb fragment (P3: 5 0 -CAGTTTACCCGC-TCTGCTAC-3 0 ).
Histological analysis
For histological analysis, embryos were fixed in Bouin's fixative (Sigma), dehydrated, embedded in paraffin, sectioned at 10 mm, and stained with hematoxylin and eosin (Sigma) or periodic acid-Schiff (PAS) (Merck) according to the manufacturer's protocols.
Determination of dry lung tissue weight
Lungs were dissected from E18.5 embryos after Csection and their wet weight measured. To determine the dry weight, whole lungs were transferred to Eppendorf tubes and the tissue was dried under vacuum overnight at room temperature.
In situ hybridization, antibodies, and immunohistochemistry
Non-radioactive in situ hybridization was performed on 8 mm sections from paraformaldehyde-fixed and paraffinembedded tissue as described (Kanzler et al., 1998) . The Nfib probe includes the first 365 bp of the Nfib coding region. The probe for Shh has been described (Echelard et al., 1993) . Antibodies against SP-A, SP-B, SP-C, SP-D, TGF-b1, TGF-b2, TGF-b3, TGF-b type I receptor, and TGF-b type II receptor were obtained from Santa Cruz Biotechnology. The antibody against E-cadherin was kindly provided by R. Kemler (Freiburg). Immunohistochemical staining was performed using the ImmunoCruz Staining System (Santa Cruz Biotechnology) according to the manufacturer's or provider's protocol on sections prepared as for in situ hybridization.
